相关实验视频

Updated: May 13, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

在体外功能分析可以帮助HNF1B-MODY的精确诊断

Aishwarya Pavithram¹, Haichen Zhang², Kristin A Maloney²

¹Mohn Research Center for Diabetes Precision Medicine, Department of Clinical Science, University of Bergen, Bergen, Norway.

The Journal of molecular diagnostics : JMD

|April 4, 2024

概括

功能性测试有助于对肝细胞核因子 (HNF) 1B基因变异进行分类,以诊断成熟期糖尿病. 这项研究确定了严重的功能丧失变体和确认的良性影响,改善了HNF1B-糖尿病诊断.

科学领域:

遗传学和分子生物学
内分泌学在内分泌学.
精准医学是一门精准的医学.

背景情况:

对序列变异的准确分类对于精准医学至关重要.
肝细胞核因子 (HNF) 1B 年轻人成熟期糖尿病需要精确的诊断以获得最佳的管理和遗传咨询.
对HNF1B变异的功能性表征可以帮助解释病原性.

研究的目的:

在HNF1B基因中功能性地表征变异.
将功能数据与临床,生化和in silico发现相关联.
为了提高 HNF1B 相关糖尿病和相关疾病的诊断准确度.

主要方法:

实验室功能测试被用来评估变异的影响.
功能性试验的数据与临床,生化和in silico信息相结合.
分析了313名疑似单一性糖尿病和/或病患者.

主要成果:

两个变体 (p.A167P,p.H336Pfs22) 显示严重的功能丧失,影响了交换活化和DNA结合或mRNA稳定性.
携带p.H336Pfs22变体的携带者出现了糖尿病和先天缺失.
五种变种 (p.D82N,p.T88A,p.N394D,p.V458G,p.T544A) 显示出良性功能影响.

结论:

功能性表征提供了对HNF1B变体致病性的关键见解.
该研究确定了致病性和良性HNF1B变异,有助于诊断和管理.
试行了新的方法,推进了HNF1B-糖尿病的诊断.

更多相关视频

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

相关概念视频

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.